Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
421 A first-in-human (FIH) phase I/IIa clinical trial assessing a ribonucleic acid lipoplex (RNA-LPX) encoding shared tumor antigens for immunotherapy of prostate cancer; preliminary analysis of PRO-MERIT
Compose a Response to This Article
Other responses
No responses have been published for this article.